New TB tools need to be affordable in the private sector: The case study of Xpert MTB/RIF

A new 13-country patient pathway analysis published in the Journal of Epidemiology and Global Health presents updated data on what patients pay for Xpert MTB/RIF testing in the private health sector in highly privatized health markets.

To subscribe to the Weekly Newsletter of new posts, enter your email here:


By Journal of Epidemiology and Global Health

Published: May 10, 2018, 9:28 a.m.

Last updated: May 10, 2018, 11:32 a.m.

Print Share